Acceptability of a Chlamydia Vaccine Among Young Women and Men in Birmingham, Alabama, USA: 2023–2025
Open Forum Infectious Diseases · 30.03.2026 · 13 (4)
DOI: 10.1093/ofid/ofag166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 19.03.2026. Verfasst von Kanupriya Gupta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine; University of Alabama at Birmingham, Birmingham, Alabama, USA. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
Background
Chlamydia infection remains a global health concern, justifying the need for a chlamydia vaccine. Chlamydia infection rates are highest among young women and men; thus, they would be the target populations for vaccination. However, vaccine availability does not ensure uptake. We conducted a survey among youth to identify factors that may influence chlamydia vaccine acceptability.
Methods
Females and males aged 16–29 years seen for care in adolescent, gynecology, student health, and sexual health clinics completed a computer-assisted survey, collecting information on sexual health, health care utilization, vaccination history, and factors related to chlamydia and vaccine acceptability.
Results
Of 399 female and 221 male participants, most (93.2%) had heard of chlamydia, 28.1% reported prior chlamydia infection, and 52.6% believed they could acquire chlamydia infection. Interest in chlamydia vaccination was reported by 42.4% females and associated with non-Black race, Hispanic ethnicity, clinic site, previous influenza or COVID-19 vaccination, and awareness of human papillomavirus vaccination. Among males, 44.8% reported chlamydia vaccination interest that was associated with ethnicity, human papillomavirus vaccine awareness, chlamydia awareness, prior chlamydia infection, and possibility of acquiring chlamydia infection. Among all participants, most (82.5%) reported their main motivation for vaccination was to protect themselves and major barriers were concerns about safety (50.0%) and cost (23.1%). The majority (66.0%) reported health care providers as the main resource for vaccine information and were more likely to get vaccinated if recommended by them.
Conclusions
Less than half of surveyed youth were interested in receiving a chlamydia vaccine. Findings will guide strategies for chlamydia vaccine implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine; University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Heersink School of Medicine; University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Obstetrics and Gynecology; University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Pediatrics; University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Kristal J Aaron, Samantha V Hill, Barbara Van Der Pol, William M Geisler
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Gupta, K., Gamble, B. I., D'Amico, M. J., Pentala, A., Hu, M., Shiry, R. J., Aaron, K. J., Arbuckle, J. L., Hill, S. V., Van Der Pol, B., & Geisler, W. M. (2026). Acceptability of a Chlamydia Vaccine Among Young Women and Men in Birmingham, Alabama, USA: 2023–2025. Open Forum Infectious Diseases, 13(4). https://doi.org/10.1093/ofid/ofag166
Vancouver
Gupta K, Gamble BI, D'Amico MJ, Pentala A, Hu M, Shiry RJ, et al. Acceptability of a Chlamydia Vaccine Among Young Women and Men in Birmingham, Alabama, USA: 2023–2025. Open Forum Infectious Diseases. 2026;13(4). doi:10.1093/ofid/ofag166
BibTeX
@article{Gupta2026,
author = {Gupta, Kanupriya and Gamble, Bria I and D'Amico, Madison J and Pentala, Aamuktha and Hu, Muhan and Shiry, Rebecca J and Aaron, Kristal J and Arbuckle, Janeen L and Hill, Samantha V and Van Der Pol, Barbara and Geisler, William M},
title = {Acceptability of a Chlamydia Vaccine Among Young Women and Men in Birmingham, Alabama, USA: 2023–2025},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {4},
doi = {10.1093/ofid/ofag166}
}
EUVIMED